Sbir phase II, topic 326: development of novel therapeutic agents that target cancer stem cells

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201600043C
Awardee
Awarding agency
Obligated
$1,496,276

Award facts

Opportunity
  • BAAN44CO6700679 Solicitation number
Contract value 100% obligated
$1,496,276.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
San Carlos, CA 94070, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 3 $0
Other Administrative Action 2 · Development of novel therapeutic agents that target cancer stem cells $0
Supplemental Agreement for work within scope 1 $0
Original award $1,496,276

About this award

This is a $1,496,276.00 Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a civilian agency, to Cellerant Therapeutics, Inc. The contract is for the SBIR (Small Business Innovation Research) Phase II development of novel therapeutic agents that target cancer stem cells, under Topic 326. The contract has a total small business set-aside designation and was awarded on September 19, 2016 with an ultimate completion date of April 16, 2018.

Quick answers

Who was awarded contract HHSN261201600043C?

HHSN261201600043C was awarded to Cellerant Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2016.

How much is contract HHSN261201600043C worth?

The government has obligated $1,496,276 on HHSN261201600043C.

Was contract HHSN261201600043C competed?

The extent of competition for HHSN261201600043C was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award